{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T08:57:09Z","timestamp":1758704229287,"version":"3.41.2"},"reference-count":114,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Vaccines represent an important strategy to protect humans against a wide variety of pathogens and have even led to eradicating some diseases. Although every vaccine is developed to induce specific protection for a particular pathogen, some vaccine formulations can also promote trained immunity, which is a non-specific memory-like feature developed by the innate immune system. It is thought that trained immunity can protect against a wide variety of pathogens other than those contained in the vaccine formulation. The non-specific memory of the trained immunity-based vaccines (TIbV) seems beneficial for the immunized individual, as it may represent a powerful strategy that contributes to the control of pathogen outbreaks, reducing morbidity and mortality. A wide variety of respiratory viruses, including respiratory syncytial virus (hRSV) and metapneumovirus (hMPV), cause serious illness in children under 5 years old and the elderly. To address this public health problem, we have developed recombinant BCG vaccines that have shown to be safe and immunogenic against hRSV or hMPV. Besides the induction of specific adaptive immunity against the viral antigens, these vaccines could generate trained immunity against other respiratory pathogens. Here, we discuss some of the features of trained immunity induced by BCG and put forward the notion that recombinant BCGs expressing hRSV or hMPV antigens have the capacity to simultaneously induce specific adaptive immunity and non-specific trained immunity. These recombinant BCG vaccines could be considered as TIbV capable of inducing simultaneously the development of specific protection against hRSV or hMPV, as well as non-specific trained-immunity-based protection against other pathogenic viruses.<\/jats:p>","DOI":"10.3389\/fimmu.2020.611946","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T04:30:59Z","timestamp":1609993859000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Induction of Trained Immunity by Recombinant Vaccines"],"prefix":"10.3389","volume":"11","author":[{"given":"Camila","family":"Covi\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"R\u00edos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roslye V.","family":"Berr\u00edos-Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan M.","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis M.","family":"Kalergis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2011.04.006","article-title":"Trained immunity: A memory for innate host defense","volume":"9","author":"Netea","year":"2011","journal-title":"Cell Host Microbe"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003035","article-title":"NK cells and immune \u201cmemory","volume":"186","author":"Sun","year":"2011","journal-title":"J Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cell.2017.11.034","article-title":"Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity","volume":"172","author":"Mitroulis","year":"2018","journal-title":"Cell"},{"key":"B5","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","article-title":"BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis","volume":"172","author":"Kaufmann","year":"2018","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.12.005","article-title":"I Remember You: Epigenetic Priming in Epithelial Stem Cells","volume":"47","author":"Novakovic","year":"2017","journal-title":"Immunity"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nature24271","article-title":"Inflammatory memory sensitizes skin epithelial stem cells to tissue damage","volume":"550","author":"Naik","year":"2017","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1016\/j.celrep.2019.08.004","article-title":"\u03b2-Glucan-Induced Trained Immunity Protects against Leishmania braziliensis Infection: a Crucial Role for IL-32","volume":"28","author":"dos Santos","year":"2019","journal-title":"Cell Rep"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2012.06.006","article-title":"Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes","volume":"12","author":"Quintin","year":"2012","journal-title":"Cell Host Microbe"},{"key":"B10","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1189\/jlb.4MA0215-059R","article-title":"Long-term in vitro and in vivo effects of \u03b3-irradiated BCG on innate and adaptive immunity","volume":"98","author":"Arts","year":"2015","journal-title":"J Leukoc Biol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz692","article-title":"Trained Immunity Confers Broad-Spectrum Protection Against Bacterial Infections","volume":"222","author":"Ciarlo","year":"2020","journal-title":"J Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1159\/000355628","article-title":"Long-lasting effects of BCG vaccination on both heterologous Th1\/Th17 responses and innate trained immunity","volume":"6","author":"Kleinnijenhuis","year":"2015","journal-title":"Innate Immun"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-015-1497-8","article-title":"Child survival and BCG vaccination: A community based prospective cohort study in Uganda","volume":"15","author":"Nankabirwa","year":"2015","journal-title":"BMC Public Health"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ144","article-title":"Nonspecific (heterologous) protection of neonatal BCG vaccination against hospitalization due to respiratory infection and sepsis","volume":"60","author":"De Castro","year":"2015","journal-title":"Clin Infect Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00026","article-title":"Assessing the Importance of Domestic Vaccine Manufacturing Centers: An Overview of Immunization Programs, Vaccine Manufacture, and Distribution","volume":"9","author":"Rey-Jurado","year":"2018","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2016.09.009","article-title":"The vaccine development process","volume":"56","author":"Rolling","year":"2016","journal-title":"J Am Pharm Assoc"},{"unstructured":"Global World Health Organization2018","key":"B19"},{"key":"B20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.smim.2018.06.002","article-title":"Non-specific effects of vaccines: Current evidence and potential implications","volume":"39","author":"De Bree","year":"2018","journal-title":"Semin Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1215761109","article-title":"Saving lives by training innate immunity with bacille Calmette-Gu\u00e9rin vaccine","volume":"109","author":"Aaby","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/trstmh\/tru168","article-title":"Trained immunity: consequences for the heterologous effects of BCG vaccination","volume":"109","author":"Kleinnijenhuis","year":"2015","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"B23","article-title":"Neonatal BCG protection against tuberculosis lasts for 20 years in Brazil","volume":"9","author":"Barreto","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.d5974","article-title":"How does the level of BCG vaccine protection against tuberculosis fall over time","volume":"343","author":"Rodrigues","year":"2011","journal-title":"BMJ"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1126\/science.1184784","article-title":"Tuberculosis: What We Don \u2018 t Know","volume":"328","author":"Russell","year":"2010","journal-title":"Sci (80- )"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1001\/jama.291.17.2086","article-title":"Long-term efficacy of BCG vaccine","volume":"291","author":"Aronson","year":"2004","journal-title":"J Am Med Assoc"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6082.293","article-title":"BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life","volume":"2","author":"Hart","year":"1977","journal-title":"Br Med J"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.02806","article-title":"BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design","volume":"10","author":"Covi\u00e1n","year":"2019","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00407\/full","article-title":"Immune Responses to Bacillus Calmette\u2013Gu\u00e9rin Vaccination: Why Do They Fail to Protect against Mycobacterium tuberculosis","volume":"8","author":"Moliva","year":"2017","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1999.00818.x","article-title":"Enhanced antigen-presenting activity and tumour necrosis factor-\u03b1- independent activation of dendritic cells following treatment with Mycobacterium bovis bacillus Calmette-Guerin","volume":"97","author":"Kim","year":"1999","journal-title":"Immunology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.8.5324","article-title":"Mycobacterium bovis BCG Attenuates Surface Expression of Mature Class II Molecules through IL-10-Dependent Inhibition of Cathepsin S","volume":"175","author":"Sendide","year":"2005","journal-title":"J Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/(SICI)1521-4141(199906)29:06<1972::AID-IMMU1972>3.0.CO;2-1","article-title":"Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bacillus Calmette Guerin-infected dendritic cells","volume":"67","author":"Demangel","year":"1999","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.8.4647-4656.2003","article-title":"Stimulation of Neutrophil Granulocytes with Mycobacterium bovis Bacillus Calmette-Gu\u00e9rin Induces Changes in Phenotype and Gene Expression and Inhibits Spontaneous Apoptosis","volume":"71","author":"Suttmann","year":"2003","journal-title":"Infect Immun"},{"key":"B34","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/ije\/dyw120","article-title":"Vaccinations against smallpox and tuberculosis are associated with better long-term survival: A Danish case-cohort study 1971-2010","volume":"46","author":"Rieckmann","year":"2017","journal-title":"Int J Epidemiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.04.045","article-title":"Vaccinia scars associated with better survival for adults. An observational study from Guinea-Bissau","volume":"24","author":"Aaby","year":"2006","journal-title":"Vaccine"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir240","article-title":"Randomized Trial of BCG Vaccination at Birth to Low-Birth-Weight Children: Beneficial Nonspecific Effects in the Neonatal Period","volume":"204","author":"Aaby","year":"2011","journal-title":"J Infect Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/bmj.311.7003.481","article-title":"Non-specific beneficial effect of measles immunisation: Analysis of mortality studies from developing countries","volume":"311","author":"Aaby","year":"1995","journal-title":"BMJ"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1136\/bmj.c6495","article-title":"Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: Randomised controlled trial","volume":"341","author":"Aaby","year":"2010","journal-title":"BMJ"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpubh.2018.00013","article-title":"National Immunization Campaigns with Oral Polio Vaccine Reduce All-Cause Mortality: A Natural Experiment within Seven Randomized Trials","volume":"6","author":"Andersen","year":"2018","journal-title":"Front Public Heal"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ617","article-title":"The Effect of Oral Polio Vaccine at Birth on Infant Mortality: A Randomized Trial","volume":"61","author":"Lund","year":"2015","journal-title":"Clin Infect Dis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2014.10.005","article-title":"BCG-induced trained immunity in NK cells: Role for non-specific protection to infection","volume":"155","author":"Kleinnijenhuis","year":"2014","journal-title":"Clin Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","article-title":"BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis","volume":"172","author":"Kaufmann","year":"2018","journal-title":"Cell"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.09.006","article-title":"Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls","volume":"23","author":"Stensballe","year":"2005","journal-title":"Vaccine"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0806244105","article-title":"Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG","volume":"105","author":"Bueno","year":"2008","journal-title":"Proc Natl Acad Sci"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02875","article-title":"Recombinant BCG Vaccines Reduce Pneumovirus-Caused Airway Pathology by Inducing Protective Humoral Immunity","volume":"9","author":"Soto","year":"2018","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20170355","article-title":"The fate and lifespan of human monocyte subsets in steady state and systemic inflammation","volume":"214","author":"Patel","year":"2017","journal-title":"J Exp Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.08.040190.001511","article-title":"Lymphokine control of in vivo immunoglobulin isotype selection","volume":"8","author":"Finkelman","year":"1990","journal-title":"Annu Rev Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/0962-8479(92)90146-B","article-title":"The humoral immune response after BCG vaccination: an immunoblotting study using two purified antigens","volume":"73","author":"Drowart","year":"1992","journal-title":"Tuber Lung Dis"},{"key":"B49","article-title":"The efficacy of Bacillus Calmette-Guerin vaccinations for the prevention of acute upper respiratory tract infection in the elderly","volume":"43","author":"Wardhana, Datau","year":"2011","journal-title":"Acta Med Indones"},{"key":"B50","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cell.2020.08.051","article-title":"Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly","volume":"183","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2018.05.007","article-title":"Severe community-acquired pneumonia due to Pseudomonas aeruginosa coinfection in an influenza A(H1N1)pdm09 patient","volume":"52","author":"Su","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2019.05.007","article-title":"Characteristics of community-acquired respiratory viruses infections except seasonal influenza in transplant recipients and non-transplant critically ill patients","author":"Lee","year":"2019","journal-title":"J Microbiol Immunol Infect [Preprint]"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2018.11.004","article-title":"Recommendations and guidelines for the treatment of pneumonia in Taiwan","volume":"52","author":"Chou","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2019.05.014","article-title":"Community-acquired adenoviral and pneumococcal pneumonia complicated by pulmonary aspergillosis in an immunocompetent adult","volume":"52","author":"Lee","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) and coronavirus disease-2019 ( COVID-19 ): The epidemic and the challenges","volume":"55","author":"Lai","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"B56","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jcv.2011.10.002","article-title":"Ten years of human metapneumovirus research","volume":"53","author":"Feuillet","year":"2012","journal-title":"J Clin Virol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.27.20029009v1","article-title":"Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China","author":"Huang","year":"2020","journal-title":"medRxiv [Preprint]"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.200711","article-title":"Temporal estimates of case-fatality rate for COVID-19 outbreaks in Canada and the United States","author":"Moghadas","year":"2020","journal-title":"CMAJ [Preprint]"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-020-01221-y","article-title":"The race for coronavirus vaccines","volume":"580","author":"Callaway","year":"2020","journal-title":"Nature"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-020-00073-5","article-title":"The COVID-19 vaccine development landscape","volume":"19","author":"Thanh Le","year":"2020","journal-title":"Nat Rev Drug Discovery"},{"key":"B61","doi-asserted-by":"publisher","first-page":"eabc1463","DOI":"10.1126\/sciadv.abc1463","article-title":"Mandated Bacillus Calmette-Gu\u00e9rin (BCG) vaccination predicts flattened curves for the spread of COVID-19","volume":"6","author":"Berg","year":"2020","journal-title":"Sci Adv"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.4046\/trd.2020.0063","article-title":"COVID-19 death and BCG vaccination programs worldwide","author":"Jirjees","year":"2020","journal-title":"Tuberc Respir Dis (Seoul) [Preprint]"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40794-020-00117-z","article-title":"Correlation between immunity from BCG and the morbidity and mortality of COVID-19","volume":"6","author":"Wickramasinghe","year":"2020","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.7774\/cevr.2020.9.2.179","article-title":"Current national policies for infant universal bacille calmettegu\u00e9rin vaccination were associated with lower mortality from coronavirus disease 2019","volume":"9","author":"Ebina-Shibuya","year":"2020","journal-title":"Clin Exp Vaccine Res"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00970","article-title":"Could BCG vaccination induce protective trained immunity for SARS-CoV-2","volume":"11","author":"Covi\u00e1n","year":"2020","journal-title":"Front Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3113\/JSOA.2020.0036","article-title":"Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study","author":"Miller","year":"2020","journal-title":"medRxiv [Preprint]"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2014.09.006","article-title":"BCG-induced protection: Effects on innate immune memory","volume":"26","author":"Netea","year":"2014","journal-title":"Semin Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J Urol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1159\/000273461","article-title":"Bacillus calmette-gu\u00e9rin versus gemcitabine for intravesical therapy in high-risk superficial bladder cancer: A randomised prospective study","volume":"84","author":"Porena","year":"2010","journal-title":"Urol Int"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2014.02.061","article-title":"Bacillus calmette-gu\u00e9rin strain differences have an impact on clinical outcome in bladder cancer immunotherapy","volume":"66","author":"Rentsch","year":"2014","journal-title":"Eur Urol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.eururo.2009.09.038","article-title":"Bacillus Calmette-Gu\u00e9rin Is Superior to a Combination of Epirubicin and Interferon-\u03b12b in the Intravesical Treatment of Patients with Stage T1 Urinary Bladder Cancer. A Prospective, Randomized, Nordic Study","volume":"57","author":"Duchek","year":"2010","journal-title":"Eur Urol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2015.08.075","article-title":"Randomized Controlled Study of the Efficacy, Safety and Quality of Life with Low Dose bacillus Calmette-Gu\u00e9rin Instillation Therapy for Nonmuscle Invasive Bladder Cancer","volume":"195","author":"Yokomizo","year":"2016","journal-title":"J Urol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-020-1768-y","article-title":"Current status and future perspectives of immunotherapy in bladder cancer treatment","author":"Wu","year":"2020","journal-title":"Sci China Life Sci"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical Bacillus Calmette-Guerin Reduces the Risk of Progression in Patients With Superficial Bladder Cancer: A Meta-Analysis of the Published Results of Randomized Clinical Trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2012.01848.x","article-title":"Treatment of common and plane warts in children with topical viable bacillus calmette-guerin","volume":"30","author":"Salem","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3038.2007.00669.x","article-title":"Potential health effects from non-specific stimulation of the immune function in early age: The example of BCG vaccination","volume":"19","author":"Rousseau","year":"2008","journal-title":"Pediatr Allergy Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.04.020","article-title":"Non-specific effects of BCG vaccine on viral infections","volume":"25","author":"Moorlag","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.aax4517","article-title":"BCG vaccination\u2013induced emergency granulopoiesis provides rapid protection from neonatal sepsis","volume":"12","author":"Brook","year":"2020","journal-title":"Sci Transl Med"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02936","article-title":"Trained Immunity-Based Vaccines: A New Paradigm for the Development of Broad-Spectrum Anti-infectious Formulations","volume":"9","author":"S\u00e1nchez-Ram\u00f3n","year":"2018","journal-title":"Front Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1159\/000355628","article-title":"Long-lasting effects of bcg vaccination on both heterologous th1\/th17 responses and innate trained immunity","volume":"6","author":"Kleinnijenhuis","year":"2014","journal-title":"J Innate Immun"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf3036","article-title":"An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells","volume":"352","author":"Zanoni","year":"2016","journal-title":"Sci (80- )"},{"key":"B82","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.molimm.2019.02.021","article-title":"The Mycobacterium tuberculosis glycoprotein Rv1016c protein inhibits dendritic cell maturation, and impairs Th1\/Th17 responses during mycobacteria infection","volume":"109","author":"Su","year":"2019","journal-title":"Mol Immunol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1005206","article-title":"BCG Skin Infection Triggers IL-1R-MyD88- Dependent Migration of EpCAM low CD11b high Skin Dendritic cells to Draining Lymph Node During CD4 + T-Cell Priming","volume":"11","author":"Bollampalli","year":"2015","journal-title":"PLoS Pathog"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200737905","article-title":"Mycobacterium bovis BCG-infected neutrophils and dendritic cells cooperate to induce specific T cell responses in humans and mice","author":"Morel","year":"2008","journal-title":"Eur J Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv332","article-title":"BCG-vaccination enhances immunogenicity of subsequent influenza vaccination in healthy volunteers: a randomized placebo-controlled pilot study","volume":"212","author":"Leentjens","year":"2015","journal-title":"J Infect Dis"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-016-0123-0","article-title":"Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries","volume":"5","author":"Bont","year":"2016","journal-title":"Infect Dis Ther"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis","volume":"375","author":"Nair","year":"2010","journal-title":"Lancet"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30938-8","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study","volume":"390","author":"Shi","year":"2017","journal-title":"Lancet"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.12.048","article-title":"A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice","volume":"35","author":"C\u00e9spedes","year":"2017","journal-title":"Vaccine"},{"key":"B90","doi-asserted-by":"publisher","first-page":"100517","DOI":"10.1016\/j.eclinm.2020.100517","article-title":"Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial","volume":"27","author":"Abarca","year":"2020","journal-title":"EClinicalMedicine"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903452","article-title":"Efficient Lung Recruitment of Respiratory Syncytial Virus-Specific Th1 Cells Induced by Recombinant Bacillus Calmette-Gu\u00e9rin Promotes Virus Clearance and Protects from Infection","volume":"185","author":"Cautivo","year":"2010","journal-title":"J Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1334026","article-title":"A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus","volume":"13","author":"Rey-Jurado","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30292-5","article-title":"The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates","volume":"18","author":"Mazur","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3390\/v12060637","article-title":"Pathogenesis and Resolution of hRSV and hMPV Infections","volume":"12","author":"Andrade","year":"2020","journal-title":"Viruses"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/89098","article-title":"A newly discovered human pneumovirus isolated from young children with respiratory tract disease","volume":"7","author":"Van Den Hoogen","year":"2001","journal-title":"Nat Med"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-50340-8","article-title":"Epidemiology, evolution and transmission of human metapneumovirus in Guangzhou China, 2013\u20132017","volume":"9","author":"Yi","year":"2019","journal-title":"Sci Rep"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2019.11.012","article-title":"Epidemiological and genetic characteristics of human metapneumovirus in pediatric patients across six consecutive seasons in Beijing, China","volume":"91","author":"Zhu","year":"2020","journal-title":"Int J Infect Dis"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1300118","article-title":"Immunization with a Recombinant Bacillus Calmette\u2013Gu\u00e9rin Strain Confers Protective Th1 Immunity against the Human Metapneumovirus","volume":"192","author":"Palavecino","year":"2014","journal-title":"J Immunol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.smim.2015.03.005","article-title":"Early IFN type I response: Learning from microbial evasion strategies","volume":"27","author":"Coccia","year":"2015","journal-title":"Semin Immunol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"4S","DOI":"10.1016\/S0002-9343(01)01058-0","article-title":"Epidemiology of Respiratory Infection","volume":"112","author":"Monto","year":"2002","journal-title":"Am J Med"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2017.01134","article-title":"What have we learnt about BCG vaccination in the last 20 years","volume":"8","author":"Dockrell","year":"2017","journal-title":"Front Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0337-y","article-title":"BCG-induced trained immunity: can it offer protection against COVID-19","volume":"20","author":"O\u2019Neill","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcibr2011679","article-title":"Trained Innate Immunity, Epigenetics, and Covid-19","volume":"383","author":"Mantovani","year":"2020","journal-title":"N Engl J Med"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.04.042","article-title":"Trained immunity: a tool for reducing susceptibility and severity of SARS-CoV2 infection","volume":"181","author":"Netea","year":"2020","journal-title":"Cell Press"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2020.104187","article-title":"New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19","volume":"356","author":"Gupta","year":"2020","journal-title":"Cell Immunol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2020.01050","article-title":"BCG Against SARS-CoV-2: Second Youth of an Old Age Vaccine","volume":"11","author":"Kamat","year":"2020","journal-title":"Front Pharmacol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1111\/resp.13885","article-title":"National policies for paediatric universal BCG vaccination were associated with decreased mortality due to COVID-19","volume":"25","author":"Ebina-Shibuya","year":"2020","journal-title":"Respirology"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.08.018","article-title":"The effect of Bacillus Calmette\u2013Gu\u00e9rin (BCG) vaccination in preventing sever infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic","volume":"38","author":"Yitbarek","year":"2020","journal-title":"Vaccine"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2017.01147","article-title":"The recombinant bacille Calmette-Gu\u00e9rin vaccine VPM1002: Ready for clinical efficacy testing","volume":"8","author":"Nieuwenhuizen","year":"2017","journal-title":"Front Immunol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.8.5647","article-title":"Bacillus Calmette Guerin Vaccination of Human Newborns Induces a Specific, Functional CD8+ T Cell Response","volume":"177","author":"Murray","year":"2014","journal-title":"J Immunol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1196\/annals.1358.010","article-title":"The immune response to BCG vaccination of newborns","volume":"1062","author":"Hanekom","year":"2005","journal-title":"Ann New York Acad Sci"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/S0962-8479(05)80013-9","article-title":"Humoral immune response in infants after BCG vaccination","volume":"76","author":"Beyazova","year":"1995","journal-title":"Tuber Lung Dis"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201747024","article-title":"Human dendritic cells activated with MV130 induce Th1, Th17 and IL-10 responses via RIPK2 and MyD88 signalling pathways","volume":"48","author":"Cirauqui","year":"2018","journal-title":"Eur J Immunol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/S0264-410X(02)00623-0","article-title":"The global value of vaccination","volume":"21","author":"Ehreth","year":"2003","journal-title":"PharmacoEconomics Outcomes News"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.611946\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T04:31:02Z","timestamp":1609993862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.611946\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":114,"alternative-id":["10.3389\/fimmu.2020.611946"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.611946","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"article-number":"611946"}}